Premium
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-06-02 | Ms. Lori D. KochCEO & Director | -260,98 | 12,74k | Vente | 48,82 | 345,17k | -0,08% |
| 2026-05-31 | Ms. Lori D. KochCEO & Director | -4,67k | 224,42k | Sale to Issuer | 48,03 | 345,17k | -1,34% |
| 2026-05-31 | Ms. Antonella B. FranzenSenior VP & CFO | -1,56k | 74,84k | Sale to Issuer | 48,03 | 68,81k | -2,21% |
| 2026-05-04 | Mr. Edward D. BreenNon-Executive Chairman | -11,54k | 525,45k | Sale to Issuer | 45,54 | 273,98k | -4,04% |
| 2026-05-04 | Ms. Antonella B. FranzenSenior VP & CFO | -245,84 | 11,20k | Sale to Issuer | 45,54 | 70,37k | -0,35% |
| 2026-05-04 | Mr. Erik T. HooverSenior VP & General Counsel | -1,53k | 69,48k | Sale to Issuer | 45,54 | 115,97k | -1,30% |
| 2026-05-04 | Ms. Lori D. KochCEO & Director | -3,05k | 138,82k | Sale to Issuer | 45,54 | 349,85k | -0,86% |
| 2026-05-04 | Mr. Christopher P. RaiaChief HR Officer | -1,27k | 57,85k | Sale to Issuer | 45,54 | 85,91k | -1,46% |
| 2026-02-21 | Mr. Jeroen BloemhardPresident of Healthcare & Water Technologies | -1,03k | 51,77k | Sale to Issuer | 50,36 | 24,77k | -3,98% |
| 2026-02-21 | Mr. Erik T. HooverSenior VP & General Counsel | -2,58k | 130,08k | Sale to Issuer | 50,36 | 117,27k | -2,16% |
| 2026-02-21 | Ms. Antonella B. FranzenSenior VP & CFO | -1,63k | 82,14k | Sale to Issuer | 50,36 | 70,36k | -2,27% |
| 2026-02-21 | Ms. Lori D. KochCEO & Director | -8,12k | 409,07k | Sale to Issuer | 50,36 | 351,85k | -2,26% |
| 2026-02-21 | Mr. Matthew S. AbbottSVP, Chief Information Officer & Chief Procurement Officer | -805,00 | 40,54k | Sale to Issuer | 50,36 | 12,45k | -6,08% |
| 2026-02-21 | Mr. Christopher P. RaiaChief HR Officer | -2,26k | 113,86k | Sale to Issuer | 50,36 | 86,99k | -2,53% |
| 2026-02-21 | Mr. Edward D. BreenNon-Executive Chairman | -8,71k | 438,64k | Sale to Issuer | 50,36 | 284,77k | -2,97% |
| 2026-02-15 | Mr. Christopher P. RaiaChief HR Officer | -920,00 | 45,63k | Sale to Issuer | 49,60 | 79,34k | -1,15% |
| 2026-02-15 | Mr. Edward D. BreenNon-Executive Chairman | -7,57k | 375,30k | Sale to Issuer | 49,60 | 293,48k | -2,51% |
| 2026-02-15 | Mr. Erik T. HooverSenior VP & General Counsel | -1,08k | 53,37k | Sale to Issuer | 49,60 | 107,95k | -0,99% |
| 2026-02-15 | Ms. Lori D. KochCEO & Director | -1,97k | 97,66k | Sale to Issuer | 49,60 | 280,62k | -0,70% |
| 2026-02-15 | Ms. Antonella B. FranzenSenior VP & CFO | -148,00 | 7,34k | Sale to Issuer | 49,60 | 52,15k | -0,28% |
| 2026-02-15 | Mr. Jeroen BloemhardPresident of Healthcare & Water Technologies | -259,00 | 12,85k | Sale to Issuer | 49,60 | 15,88k | -1,60% |
| 2025-12-31 | Mr. Edward D. BreenNon-Executive Chairman | -24,57k | 992,84k | Sale to Issuer | 40,40 | 301,05k | -7,55% |
| 2025-12-31 | Mr. Christopher P. RaiaChief HR Officer | -2,79k | 112,84k | Sale to Issuer | 40,40 | 80,26k | -3,36% |
| 2025-12-31 | Mr. Erik T. HooverSenior VP & General Counsel | -3,35k | 135,47k | Sale to Issuer | 40,40 | 109,03k | -2,98% |
| 2025-12-31 | Ms. Lori D. KochCEO & Director | -6,70k | 270,86k | Sale to Issuer | 40,40 | 282,59k | -2,32% |
| 2025-12-31 | Ms. Antonella B. FranzenSenior VP & CFO | -536,00 | 21,66k | Sale to Issuer | 40,40 | 52,30k | -1,01% |
| 2025-12-17 | Mr. Edward D. BreenNon-Executive Chairman | -6,06k | 246,11k | Sale to Issuer | 40,61 | 325,62k | -1,83% |
| 2025-11-28 | Ms. Lori D. KochCEO & Director | -9,01k | 103,27k | Derivative Exercise and Sale | 28,00 - 39,46 | 288,33k | - |
| 2025-11-28 | Mr. Erik T. HooverSenior VP & General Counsel | -6,01k | 70,80k | Derivative Exercise and Sale | 28,00 - 39,79 | 112,10k | - |
| 2025-11-01 | Mr. Steven P. LarrabeeInitié | -6,38k | 217,82k | Sale to Issuer | 34,12 | 45,51k | -12,30% |
| 2025-09-15 | Mr. Steven P. LarrabeeInitié | -39,21k | 606,89k | Derivative Exercise and Sale | 53,50 - 77,19 | 38,73k | - |
| 2025-09-15 | Mr. Steven P. LarrabeeInitié | -4,00k | 307,92k | Vente | 76,98 | 38,73k | -9,36% |
| 2025-09-04 | Mr. Steven P. LarrabeeInitié | -25,00k | 261,00k | Derivative Exercise and Sale | 66,06 - 76,50 | 42,73k | - |
| 2025-09-05 | Mr. Steven P. LarrabeeInitié | -6,00k | 468,00k | Vente | 78,00 | 42,73k | -12,31% |
| 2025-08-20 | Mr. Edward D. BreenNon-Executive Chairman | -28,11k | 0,00 | Other Disposition | - | 137,30k | -17,00% |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
